Global RNA Therapeutics Supply, Demand and Key Producers, 2023-2029
The global RNA Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
This report studies the global RNA Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Therapeutics total market, 2018-2029, (USD Million)
Global RNA Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: RNA Therapeutics total market, key domestic companies and share, (USD Million)
Global RNA Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global RNA Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global RNA Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global RNA Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Therapeutics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global RNA Therapeutics Market, By Region:
1. How big is the global RNA Therapeutics market?
2. What is the demand of the global RNA Therapeutics market?
3. What is the year over year growth of the global RNA Therapeutics market?
4. What is the total value of the global RNA Therapeutics market?
5. Who are the major players in the global RNA Therapeutics market?
RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
This report studies the global RNA Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNA Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global RNA Therapeutics total market, 2018-2029, (USD Million)
Global RNA Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: RNA Therapeutics total market, key domestic companies and share, (USD Million)
Global RNA Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global RNA Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global RNA Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global RNA Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNA Therapeutics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global RNA Therapeutics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- mRNA
- RNA Interference (RNAi)
- Antisense Oligonucleotide (ASO)
- Other
- Hospitals
- Research Institutions
- Moderna
- Alnylam Pharmaceuticals
- Novartis
- Ionis Pharmaceuticals
- Sarepta Therapeutics
- Sanofi
- Pfizer
- Arrowhead Pharmaceuticals
- BioNTech
- Orna Therapeutics
- CRISPR Therapeutics
- Silence Therapeutics
- Astellas Pharma Inc.
- CureVac
- Sirnaomics
- Arcturus Therapeutics
- Arbutus Biopharma
1. How big is the global RNA Therapeutics market?
2. What is the demand of the global RNA Therapeutics market?
3. What is the year over year growth of the global RNA Therapeutics market?
4. What is the total value of the global RNA Therapeutics market?
5. Who are the major players in the global RNA Therapeutics market?
1 SUPPLY SUMMARY
1.1 RNA Therapeutics Introduction
1.2 World RNA Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World RNA Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World RNA Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States RNA Therapeutics Market Size (2018-2029)
1.3.3 China RNA Therapeutics Market Size (2018-2029)
1.3.4 Europe RNA Therapeutics Market Size (2018-2029)
1.3.5 Japan RNA Therapeutics Market Size (2018-2029)
1.3.6 South Korea RNA Therapeutics Market Size (2018-2029)
1.3.7 ASEAN RNA Therapeutics Market Size (2018-2029)
1.3.8 India RNA Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Therapeutics Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Therapeutics Consumption Value (2018-2029)
2.2 World RNA Therapeutics Consumption Value by Region
2.2.1 World RNA Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World RNA Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States RNA Therapeutics Consumption Value (2018-2029)
2.4 China RNA Therapeutics Consumption Value (2018-2029)
2.5 Europe RNA Therapeutics Consumption Value (2018-2029)
2.6 Japan RNA Therapeutics Consumption Value (2018-2029)
2.7 South Korea RNA Therapeutics Consumption Value (2018-2029)
2.8 ASEAN RNA Therapeutics Consumption Value (2018-2029)
2.9 India RNA Therapeutics Consumption Value (2018-2029)
3 WORLD RNA THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for RNA Therapeutics in 2022
3.3 RNA Therapeutics Company Evaluation Quadrant
3.4 RNA Therapeutics Market: Overall Company Footprint Analysis
3.4.1 RNA Therapeutics Market: Region Footprint
3.4.2 RNA Therapeutics Market: Company Product Type Footprint
3.4.3 RNA Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: RNA Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: RNA Therapeutics Consumption Value Comparison
4.2.1 United States VS China: RNA Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: RNA Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based RNA Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based RNA Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Therapeutics Revenue, (2018-2023)
4.4 China Based Companies RNA Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based RNA Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based RNA Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based RNA Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 mRNA
5.2.2 RNA Interference (RNAi)
5.2.3 Antisense Oligonucleotide (ASO)
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World RNA Therapeutics Market Size by Type (2018-2023)
5.3.2 World RNA Therapeutics Market Size by Type (2024-2029)
5.3.3 World RNA Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Research Institutions
6.3 Market Segment by Application
6.3.1 World RNA Therapeutics Market Size by Application (2018-2023)
6.3.2 World RNA Therapeutics Market Size by Application (2024-2029)
6.3.3 World RNA Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Moderna
7.1.1 Moderna Details
7.1.2 Moderna Major Business
7.1.3 Moderna RNA Therapeutics Product and Services
7.1.4 Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Moderna Recent Developments/Updates
7.1.6 Moderna Competitive Strengths & Weaknesses
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Details
7.2.2 Alnylam Pharmaceuticals Major Business
7.2.3 Alnylam Pharmaceuticals RNA Therapeutics Product and Services
7.2.4 Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.2.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis RNA Therapeutics Product and Services
7.3.4 Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Details
7.4.2 Ionis Pharmaceuticals Major Business
7.4.3 Ionis Pharmaceuticals RNA Therapeutics Product and Services
7.4.4 Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Ionis Pharmaceuticals Recent Developments/Updates
7.4.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Details
7.5.2 Sarepta Therapeutics Major Business
7.5.3 Sarepta Therapeutics RNA Therapeutics Product and Services
7.5.4 Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sarepta Therapeutics Recent Developments/Updates
7.5.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi RNA Therapeutics Product and Services
7.6.4 Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer RNA Therapeutics Product and Services
7.7.4 Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Arrowhead Pharmaceuticals
7.8.1 Arrowhead Pharmaceuticals Details
7.8.2 Arrowhead Pharmaceuticals Major Business
7.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Product and Services
7.8.4 Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Arrowhead Pharmaceuticals Recent Developments/Updates
7.8.6 Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
7.9 BioNTech
7.9.1 BioNTech Details
7.9.2 BioNTech Major Business
7.9.3 BioNTech RNA Therapeutics Product and Services
7.9.4 BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BioNTech Recent Developments/Updates
7.9.6 BioNTech Competitive Strengths & Weaknesses
7.10 Orna Therapeutics
7.10.1 Orna Therapeutics Details
7.10.2 Orna Therapeutics Major Business
7.10.3 Orna Therapeutics RNA Therapeutics Product and Services
7.10.4 Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Orna Therapeutics Recent Developments/Updates
7.10.6 Orna Therapeutics Competitive Strengths & Weaknesses
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Details
7.11.2 CRISPR Therapeutics Major Business
7.11.3 CRISPR Therapeutics RNA Therapeutics Product and Services
7.11.4 CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CRISPR Therapeutics Recent Developments/Updates
7.11.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.12 Silence Therapeutics
7.12.1 Silence Therapeutics Details
7.12.2 Silence Therapeutics Major Business
7.12.3 Silence Therapeutics RNA Therapeutics Product and Services
7.12.4 Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Silence Therapeutics Recent Developments/Updates
7.12.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.13 Astellas Pharma Inc.
7.13.1 Astellas Pharma Inc. Details
7.13.2 Astellas Pharma Inc. Major Business
7.13.3 Astellas Pharma Inc. RNA Therapeutics Product and Services
7.13.4 Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Astellas Pharma Inc. Recent Developments/Updates
7.13.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.14 CureVac
7.14.1 CureVac Details
7.14.2 CureVac Major Business
7.14.3 CureVac RNA Therapeutics Product and Services
7.14.4 CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 CureVac Recent Developments/Updates
7.14.6 CureVac Competitive Strengths & Weaknesses
7.15 Sirnaomics
7.15.1 Sirnaomics Details
7.15.2 Sirnaomics Major Business
7.15.3 Sirnaomics RNA Therapeutics Product and Services
7.15.4 Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Sirnaomics Recent Developments/Updates
7.15.6 Sirnaomics Competitive Strengths & Weaknesses
7.16 Arcturus Therapeutics
7.16.1 Arcturus Therapeutics Details
7.16.2 Arcturus Therapeutics Major Business
7.16.3 Arcturus Therapeutics RNA Therapeutics Product and Services
7.16.4 Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Arcturus Therapeutics Recent Developments/Updates
7.16.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.17 Arbutus Biopharma
7.17.1 Arbutus Biopharma Details
7.17.2 Arbutus Biopharma Major Business
7.17.3 Arbutus Biopharma RNA Therapeutics Product and Services
7.17.4 Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Arbutus Biopharma Recent Developments/Updates
7.17.6 Arbutus Biopharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Therapeutics Industry Chain
8.2 RNA Therapeutics Upstream Analysis
8.3 RNA Therapeutics Midstream Analysis
8.4 RNA Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 RNA Therapeutics Introduction
1.2 World RNA Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World RNA Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World RNA Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States RNA Therapeutics Market Size (2018-2029)
1.3.3 China RNA Therapeutics Market Size (2018-2029)
1.3.4 Europe RNA Therapeutics Market Size (2018-2029)
1.3.5 Japan RNA Therapeutics Market Size (2018-2029)
1.3.6 South Korea RNA Therapeutics Market Size (2018-2029)
1.3.7 ASEAN RNA Therapeutics Market Size (2018-2029)
1.3.8 India RNA Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNA Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNA Therapeutics Major Market Trends
2 DEMAND SUMMARY
2.1 World RNA Therapeutics Consumption Value (2018-2029)
2.2 World RNA Therapeutics Consumption Value by Region
2.2.1 World RNA Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World RNA Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States RNA Therapeutics Consumption Value (2018-2029)
2.4 China RNA Therapeutics Consumption Value (2018-2029)
2.5 Europe RNA Therapeutics Consumption Value (2018-2029)
2.6 Japan RNA Therapeutics Consumption Value (2018-2029)
2.7 South Korea RNA Therapeutics Consumption Value (2018-2029)
2.8 ASEAN RNA Therapeutics Consumption Value (2018-2029)
2.9 India RNA Therapeutics Consumption Value (2018-2029)
3 WORLD RNA THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World RNA Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global RNA Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for RNA Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for RNA Therapeutics in 2022
3.3 RNA Therapeutics Company Evaluation Quadrant
3.4 RNA Therapeutics Market: Overall Company Footprint Analysis
3.4.1 RNA Therapeutics Market: Region Footprint
3.4.2 RNA Therapeutics Market: Company Product Type Footprint
3.4.3 RNA Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: RNA Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: RNA Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: RNA Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: RNA Therapeutics Consumption Value Comparison
4.2.1 United States VS China: RNA Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: RNA Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based RNA Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based RNA Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies RNA Therapeutics Revenue, (2018-2023)
4.4 China Based Companies RNA Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based RNA Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies RNA Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based RNA Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based RNA Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies RNA Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World RNA Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 mRNA
5.2.2 RNA Interference (RNAi)
5.2.3 Antisense Oligonucleotide (ASO)
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World RNA Therapeutics Market Size by Type (2018-2023)
5.3.2 World RNA Therapeutics Market Size by Type (2024-2029)
5.3.3 World RNA Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNA Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Research Institutions
6.3 Market Segment by Application
6.3.1 World RNA Therapeutics Market Size by Application (2018-2023)
6.3.2 World RNA Therapeutics Market Size by Application (2024-2029)
6.3.3 World RNA Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Moderna
7.1.1 Moderna Details
7.1.2 Moderna Major Business
7.1.3 Moderna RNA Therapeutics Product and Services
7.1.4 Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Moderna Recent Developments/Updates
7.1.6 Moderna Competitive Strengths & Weaknesses
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Details
7.2.2 Alnylam Pharmaceuticals Major Business
7.2.3 Alnylam Pharmaceuticals RNA Therapeutics Product and Services
7.2.4 Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.2.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis RNA Therapeutics Product and Services
7.3.4 Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Details
7.4.2 Ionis Pharmaceuticals Major Business
7.4.3 Ionis Pharmaceuticals RNA Therapeutics Product and Services
7.4.4 Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Ionis Pharmaceuticals Recent Developments/Updates
7.4.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Details
7.5.2 Sarepta Therapeutics Major Business
7.5.3 Sarepta Therapeutics RNA Therapeutics Product and Services
7.5.4 Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sarepta Therapeutics Recent Developments/Updates
7.5.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi RNA Therapeutics Product and Services
7.6.4 Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer RNA Therapeutics Product and Services
7.7.4 Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Arrowhead Pharmaceuticals
7.8.1 Arrowhead Pharmaceuticals Details
7.8.2 Arrowhead Pharmaceuticals Major Business
7.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Product and Services
7.8.4 Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Arrowhead Pharmaceuticals Recent Developments/Updates
7.8.6 Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
7.9 BioNTech
7.9.1 BioNTech Details
7.9.2 BioNTech Major Business
7.9.3 BioNTech RNA Therapeutics Product and Services
7.9.4 BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BioNTech Recent Developments/Updates
7.9.6 BioNTech Competitive Strengths & Weaknesses
7.10 Orna Therapeutics
7.10.1 Orna Therapeutics Details
7.10.2 Orna Therapeutics Major Business
7.10.3 Orna Therapeutics RNA Therapeutics Product and Services
7.10.4 Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Orna Therapeutics Recent Developments/Updates
7.10.6 Orna Therapeutics Competitive Strengths & Weaknesses
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Details
7.11.2 CRISPR Therapeutics Major Business
7.11.3 CRISPR Therapeutics RNA Therapeutics Product and Services
7.11.4 CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CRISPR Therapeutics Recent Developments/Updates
7.11.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
7.12 Silence Therapeutics
7.12.1 Silence Therapeutics Details
7.12.2 Silence Therapeutics Major Business
7.12.3 Silence Therapeutics RNA Therapeutics Product and Services
7.12.4 Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Silence Therapeutics Recent Developments/Updates
7.12.6 Silence Therapeutics Competitive Strengths & Weaknesses
7.13 Astellas Pharma Inc.
7.13.1 Astellas Pharma Inc. Details
7.13.2 Astellas Pharma Inc. Major Business
7.13.3 Astellas Pharma Inc. RNA Therapeutics Product and Services
7.13.4 Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Astellas Pharma Inc. Recent Developments/Updates
7.13.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
7.14 CureVac
7.14.1 CureVac Details
7.14.2 CureVac Major Business
7.14.3 CureVac RNA Therapeutics Product and Services
7.14.4 CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 CureVac Recent Developments/Updates
7.14.6 CureVac Competitive Strengths & Weaknesses
7.15 Sirnaomics
7.15.1 Sirnaomics Details
7.15.2 Sirnaomics Major Business
7.15.3 Sirnaomics RNA Therapeutics Product and Services
7.15.4 Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Sirnaomics Recent Developments/Updates
7.15.6 Sirnaomics Competitive Strengths & Weaknesses
7.16 Arcturus Therapeutics
7.16.1 Arcturus Therapeutics Details
7.16.2 Arcturus Therapeutics Major Business
7.16.3 Arcturus Therapeutics RNA Therapeutics Product and Services
7.16.4 Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Arcturus Therapeutics Recent Developments/Updates
7.16.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
7.17 Arbutus Biopharma
7.17.1 Arbutus Biopharma Details
7.17.2 Arbutus Biopharma Major Business
7.17.3 Arbutus Biopharma RNA Therapeutics Product and Services
7.17.4 Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Arbutus Biopharma Recent Developments/Updates
7.17.6 Arbutus Biopharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 RNA Therapeutics Industry Chain
8.2 RNA Therapeutics Upstream Analysis
8.3 RNA Therapeutics Midstream Analysis
8.4 RNA Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World RNA Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World RNA Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World RNA Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World RNA Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World RNA Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World RNA Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World RNA Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World RNA Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key RNA Therapeutics Players in 2022
Table 12. World RNA Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global RNA Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key RNA Therapeutics Player
Table 15. RNA Therapeutics Market: Company Product Type Footprint
Table 16. RNA Therapeutics Market: Company Product Application Footprint
Table 17. RNA Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China RNA Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China RNA Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based RNA Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based RNA Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based RNA Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 29. World RNA Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World RNA Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World RNA Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World RNA Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World RNA Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World RNA Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Moderna Basic Information, Area Served and Competitors
Table 36. Moderna Major Business
Table 37. Moderna RNA Therapeutics Product and Services
Table 38. Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Moderna Recent Developments/Updates
Table 40. Moderna Competitive Strengths & Weaknesses
Table 41. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Alnylam Pharmaceuticals Major Business
Table 43. Alnylam Pharmaceuticals RNA Therapeutics Product and Services
Table 44. Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Alnylam Pharmaceuticals Recent Developments/Updates
Table 46. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Novartis Basic Information, Area Served and Competitors
Table 48. Novartis Major Business
Table 49. Novartis RNA Therapeutics Product and Services
Table 50. Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis Recent Developments/Updates
Table 52. Novartis Competitive Strengths & Weaknesses
Table 53. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Ionis Pharmaceuticals Major Business
Table 55. Ionis Pharmaceuticals RNA Therapeutics Product and Services
Table 56. Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Ionis Pharmaceuticals Recent Developments/Updates
Table 58. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 60. Sarepta Therapeutics Major Business
Table 61. Sarepta Therapeutics RNA Therapeutics Product and Services
Table 62. Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sarepta Therapeutics Recent Developments/Updates
Table 64. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 65. Sanofi Basic Information, Area Served and Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi RNA Therapeutics Product and Services
Table 68. Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi Recent Developments/Updates
Table 70. Sanofi Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer RNA Therapeutics Product and Services
Table 74. Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Pfizer Competitive Strengths & Weaknesses
Table 77. Arrowhead Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Arrowhead Pharmaceuticals Major Business
Table 79. Arrowhead Pharmaceuticals RNA Therapeutics Product and Services
Table 80. Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 82. Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. BioNTech Basic Information, Area Served and Competitors
Table 84. BioNTech Major Business
Table 85. BioNTech RNA Therapeutics Product and Services
Table 86. BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. BioNTech Recent Developments/Updates
Table 88. BioNTech Competitive Strengths & Weaknesses
Table 89. Orna Therapeutics Basic Information, Area Served and Competitors
Table 90. Orna Therapeutics Major Business
Table 91. Orna Therapeutics RNA Therapeutics Product and Services
Table 92. Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Orna Therapeutics Recent Developments/Updates
Table 94. Orna Therapeutics Competitive Strengths & Weaknesses
Table 95. CRISPR Therapeutics Basic Information, Area Served and Competitors
Table 96. CRISPR Therapeutics Major Business
Table 97. CRISPR Therapeutics RNA Therapeutics Product and Services
Table 98. CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CRISPR Therapeutics Recent Developments/Updates
Table 100. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 101. Silence Therapeutics Basic Information, Area Served and Competitors
Table 102. Silence Therapeutics Major Business
Table 103. Silence Therapeutics RNA Therapeutics Product and Services
Table 104. Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Silence Therapeutics Recent Developments/Updates
Table 106. Silence Therapeutics Competitive Strengths & Weaknesses
Table 107. Astellas Pharma Inc. Basic Information, Area Served and Competitors
Table 108. Astellas Pharma Inc. Major Business
Table 109. Astellas Pharma Inc. RNA Therapeutics Product and Services
Table 110. Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Astellas Pharma Inc. Recent Developments/Updates
Table 112. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 113. CureVac Basic Information, Area Served and Competitors
Table 114. CureVac Major Business
Table 115. CureVac RNA Therapeutics Product and Services
Table 116. CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. CureVac Recent Developments/Updates
Table 118. CureVac Competitive Strengths & Weaknesses
Table 119. Sirnaomics Basic Information, Area Served and Competitors
Table 120. Sirnaomics Major Business
Table 121. Sirnaomics RNA Therapeutics Product and Services
Table 122. Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Sirnaomics Recent Developments/Updates
Table 124. Sirnaomics Competitive Strengths & Weaknesses
Table 125. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 126. Arcturus Therapeutics Major Business
Table 127. Arcturus Therapeutics RNA Therapeutics Product and Services
Table 128. Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Arcturus Therapeutics Recent Developments/Updates
Table 130. Arbutus Biopharma Basic Information, Area Served and Competitors
Table 131. Arbutus Biopharma Major Business
Table 132. Arbutus Biopharma RNA Therapeutics Product and Services
Table 133. Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of RNA Therapeutics Upstream (Raw Materials)
Table 135. RNA Therapeutics Typical Customers
LIST OF FIGURE
Figure 1. RNA Therapeutics Picture
Figure 2. World RNA Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RNA Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World RNA Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. RNA Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World RNA Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of RNA Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Therapeutics Markets in 2022
Figure 27. United States VS China: RNA Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RNA Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World RNA Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World RNA Therapeutics Market Size Market Share by Type in 2022
Figure 31. mRNA
Figure 32. RNA Interference (RNAi)
Figure 33. Antisense Oligonucleotide (ASO)
Figure 34. Other
Figure 35. World RNA Therapeutics Market Size Market Share by Type (2018-2029)
Figure 36. World RNA Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World RNA Therapeutics Market Size Market Share by Application in 2022
Figure 38. Hospitals
Figure 39. Research Institutions
Figure 40. RNA Therapeutics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World RNA Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World RNA Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World RNA Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World RNA Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World RNA Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World RNA Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World RNA Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World RNA Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key RNA Therapeutics Players in 2022
Table 12. World RNA Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global RNA Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key RNA Therapeutics Player
Table 15. RNA Therapeutics Market: Company Product Type Footprint
Table 16. RNA Therapeutics Market: Company Product Application Footprint
Table 17. RNA Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China RNA Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China RNA Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based RNA Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based RNA Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based RNA Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies RNA Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies RNA Therapeutics Revenue Market Share (2018-2023)
Table 29. World RNA Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World RNA Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World RNA Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World RNA Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World RNA Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World RNA Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Moderna Basic Information, Area Served and Competitors
Table 36. Moderna Major Business
Table 37. Moderna RNA Therapeutics Product and Services
Table 38. Moderna RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Moderna Recent Developments/Updates
Table 40. Moderna Competitive Strengths & Weaknesses
Table 41. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Alnylam Pharmaceuticals Major Business
Table 43. Alnylam Pharmaceuticals RNA Therapeutics Product and Services
Table 44. Alnylam Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Alnylam Pharmaceuticals Recent Developments/Updates
Table 46. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Novartis Basic Information, Area Served and Competitors
Table 48. Novartis Major Business
Table 49. Novartis RNA Therapeutics Product and Services
Table 50. Novartis RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Novartis Recent Developments/Updates
Table 52. Novartis Competitive Strengths & Weaknesses
Table 53. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Ionis Pharmaceuticals Major Business
Table 55. Ionis Pharmaceuticals RNA Therapeutics Product and Services
Table 56. Ionis Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Ionis Pharmaceuticals Recent Developments/Updates
Table 58. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 60. Sarepta Therapeutics Major Business
Table 61. Sarepta Therapeutics RNA Therapeutics Product and Services
Table 62. Sarepta Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sarepta Therapeutics Recent Developments/Updates
Table 64. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 65. Sanofi Basic Information, Area Served and Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi RNA Therapeutics Product and Services
Table 68. Sanofi RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi Recent Developments/Updates
Table 70. Sanofi Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer RNA Therapeutics Product and Services
Table 74. Pfizer RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Pfizer Competitive Strengths & Weaknesses
Table 77. Arrowhead Pharmaceuticals Basic Information, Area Served and Competitors
Table 78. Arrowhead Pharmaceuticals Major Business
Table 79. Arrowhead Pharmaceuticals RNA Therapeutics Product and Services
Table 80. Arrowhead Pharmaceuticals RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 82. Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
Table 83. BioNTech Basic Information, Area Served and Competitors
Table 84. BioNTech Major Business
Table 85. BioNTech RNA Therapeutics Product and Services
Table 86. BioNTech RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. BioNTech Recent Developments/Updates
Table 88. BioNTech Competitive Strengths & Weaknesses
Table 89. Orna Therapeutics Basic Information, Area Served and Competitors
Table 90. Orna Therapeutics Major Business
Table 91. Orna Therapeutics RNA Therapeutics Product and Services
Table 92. Orna Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Orna Therapeutics Recent Developments/Updates
Table 94. Orna Therapeutics Competitive Strengths & Weaknesses
Table 95. CRISPR Therapeutics Basic Information, Area Served and Competitors
Table 96. CRISPR Therapeutics Major Business
Table 97. CRISPR Therapeutics RNA Therapeutics Product and Services
Table 98. CRISPR Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CRISPR Therapeutics Recent Developments/Updates
Table 100. CRISPR Therapeutics Competitive Strengths & Weaknesses
Table 101. Silence Therapeutics Basic Information, Area Served and Competitors
Table 102. Silence Therapeutics Major Business
Table 103. Silence Therapeutics RNA Therapeutics Product and Services
Table 104. Silence Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Silence Therapeutics Recent Developments/Updates
Table 106. Silence Therapeutics Competitive Strengths & Weaknesses
Table 107. Astellas Pharma Inc. Basic Information, Area Served and Competitors
Table 108. Astellas Pharma Inc. Major Business
Table 109. Astellas Pharma Inc. RNA Therapeutics Product and Services
Table 110. Astellas Pharma Inc. RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Astellas Pharma Inc. Recent Developments/Updates
Table 112. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 113. CureVac Basic Information, Area Served and Competitors
Table 114. CureVac Major Business
Table 115. CureVac RNA Therapeutics Product and Services
Table 116. CureVac RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. CureVac Recent Developments/Updates
Table 118. CureVac Competitive Strengths & Weaknesses
Table 119. Sirnaomics Basic Information, Area Served and Competitors
Table 120. Sirnaomics Major Business
Table 121. Sirnaomics RNA Therapeutics Product and Services
Table 122. Sirnaomics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Sirnaomics Recent Developments/Updates
Table 124. Sirnaomics Competitive Strengths & Weaknesses
Table 125. Arcturus Therapeutics Basic Information, Area Served and Competitors
Table 126. Arcturus Therapeutics Major Business
Table 127. Arcturus Therapeutics RNA Therapeutics Product and Services
Table 128. Arcturus Therapeutics RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Arcturus Therapeutics Recent Developments/Updates
Table 130. Arbutus Biopharma Basic Information, Area Served and Competitors
Table 131. Arbutus Biopharma Major Business
Table 132. Arbutus Biopharma RNA Therapeutics Product and Services
Table 133. Arbutus Biopharma RNA Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of RNA Therapeutics Upstream (Raw Materials)
Table 135. RNA Therapeutics Typical Customers
LIST OF FIGURE
Figure 1. RNA Therapeutics Picture
Figure 2. World RNA Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RNA Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World RNA Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World RNA Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company RNA Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. RNA Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World RNA Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India RNA Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of RNA Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Therapeutics Markets in 2022
Figure 27. United States VS China: RNA Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RNA Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World RNA Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World RNA Therapeutics Market Size Market Share by Type in 2022
Figure 31. mRNA
Figure 32. RNA Interference (RNAi)
Figure 33. Antisense Oligonucleotide (ASO)
Figure 34. Other
Figure 35. World RNA Therapeutics Market Size Market Share by Type (2018-2029)
Figure 36. World RNA Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World RNA Therapeutics Market Size Market Share by Application in 2022
Figure 38. Hospitals
Figure 39. Research Institutions
Figure 40. RNA Therapeutics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
